PLGA-based nanoparticles: An overview of biomedical applications
Fabienne Danhier;Eduardo Ansorena;Joana M. Silva;Joana M. Silva;Régis Coco.
Journal of Controlled Release (2012)
3091 Citations
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
Fabienne Danhier;Olivier Feron;Véronique Préat.
Journal of Controlled Release (2010)
2590 Citations
Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.
Anne des Rieux;Virginie Fievez;Marie Garinot;Yves-Jacques Schneider.
Journal of Controlled Release (2006)
1472 Citations
RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis.
Fabienne Danhier;Aude Le Breton;Véronique Préat.
Molecular Pharmaceutics (2012)
885 Citations
Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation
Fabienne Danhier;Nathalie Lecouturier;Benoît Vroman;Christine Jérôme.
Journal of Controlled Release (2009)
650 Citations
Skin electroporation for transdermal and topical delivery
Anne-Rose Denet;Rita Vanbever;Véronique Préat.
Advanced Drug Delivery Reviews (2004)
581 Citations
Nanostructured lipid carriers: Promising drug delivery systems for future clinics.
Ana Beloqui;María Ángeles Solinís;Alicia Rodríguez-Gascón;António J. Almeida.
Nanomedicine: Nanotechnology, Biology and Medicine (2016)
458 Citations
Chitosan and chitosan derivatives in drug delivery and tissue engineering
Raphaël Riva;Héloïse Ragelle;Anne des Rieux;Nicolas Duhem.
(2011)
417 Citations
Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with Paclitaxel
Fabienne Danhier;Benoît Vroman;Nathalie Lecouturier;Nathalie Crokart.
Journal of Controlled Release (2009)
398 Citations
PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination
Marie Garinot;Virginie Fiévez;Vincent Pourcelle;François Stoffelbach.
Journal of Controlled Release (2007)
387 Citations
